Tradestie Institutional Equity Comparison Engine

DUKX vs ABVE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVE Overall Edge

ABVE Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Above Food Ingredients Inc. Common Stock (ABVE) driven by superior Growth & Margin, Options & Structure while DUKX counters with relative strength in Momentum & Technical. Fundamentally, DUKX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ABVE at N/M Forward P/E and -23.2% operating margin (-45.0% YoY). In options structure, DUKX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABVE sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DUKX N/M vs ABVE N/M Fwd P/E
Growth & Margin Winner ABVE
Op Margin N/A vs -23.2% ยท YoY N/A vs -45.0%
Momentum & Technical Winner DUKX
1Y +2.5% vs -90.2% ยท 52W Pos 35% vs 0%
Options & Structure Winner ABVE
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (8th %ile IV)
DUKX NASDAQ
Ocean Park International ETF
Institutional Equity
$26.62
-1.85% 1D
Market Cap N/A
1M Return -4.32%
1Y Return +2.49%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
1M Return -79.18%
1Y Return -90.17%
Forward P/E N/M
Unified AI Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DUKX +2.49% ABVE -90.17% Spread: +105.36 pp (DUKX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DUKX TTM Op. Margin: N/A ABVE TTM Op. Margin: -23.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DUKX vs ABVE. Trailing 12-month operating profitability (DUKX N/A vs ABVE -23.2%) and valuation multiples (DUKX N/M vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DUKX (3) vs ABVE (5)
Institutional Metric DUKX ABVE Criterion Row Winner
Market Capitalization Scale N/A $30.0M Larger Scale ABVE
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -45.0% Higher Growth ABVE
Operating Margin (TTM) Profitability N/A -23.2% Higher Margin ABVE
Net Profit Margin Profitability N/A -23.4% Higher Margin ABVE
Return on Equity (ROE) Capital Efficiency N/A 0.0% Higher ROE ABVE
52-Week Range Position Momentum 35% ($25โ€“$29) 0% ($0โ€“$7) Stronger Trend DUKX
Beta / 30D Volatility Risk Regime 0.94ฮฒ ยท 21% Vol 4.10ฮฒ ยท 310% Vol Lower Realized Risk DUKX
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite DUKX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DUKX vs ABVE Buy Guide
DUKX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DUKX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ABVE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DUKX nor ABVE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.